Clinical Trials Browser

Lymphohistiocytosis, Hemophagocytic × tocilizumab × Other hematologic neoplasm × Clear all

NCT02385110 2024-01-17

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

Phase 2 Completed

18 enrolled 10 charts

MyeloidOther hematologic neoplasm

Leukemia, Lymphohistiocytosis, Hemophagocytic